advertisement

Topcon

Cooper ML 11

Showing records 1 to 11 | Display all abstracts from Cooper ML

94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucoma
Risner ML
Molecular Neurodegeneration 2021; 16: 36
94867 Quality of referrals for glaucoma assessment: a cross-sectional survey of clinical data and outcomes
Szulborski KJ; Weintraub DS
International Ophthalmology 2021; 41: 4065-4073
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucoma
Pasini S
Molecular Neurodegeneration 2021; 16: 36
94867 Quality of referrals for glaucoma assessment: a cross-sectional survey of clinical data and outcomes
Roh S
International Ophthalmology 2021; 41: 4065-4073
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucoma
McGrady NR; D'Alessandro KB
Molecular Neurodegeneration 2021; 16: 36
94867 Quality of referrals for glaucoma assessment: a cross-sectional survey of clinical data and outcomes
Alwreikat AM; Cooper ML
International Ophthalmology 2021; 41: 4065-4073
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucoma
Yao V
Molecular Neurodegeneration 2021; 16: 36
94867 Quality of referrals for glaucoma assessment: a cross-sectional survey of clinical data and outcomes
Cotran PR
International Ophthalmology 2021; 41: 4065-4073
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucoma
Cooper ML
Molecular Neurodegeneration 2021; 16: 36
94867 Quality of referrals for glaucoma assessment: a cross-sectional survey of clinical data and outcomes
Ramsey DJ
International Ophthalmology 2021; 41: 4065-4073
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucoma
Calkins DJ
Molecular Neurodegeneration 2021; 16: 36

Issue 22-2

Change Issue


advertisement

Oculus